Wexford Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-55,000
| Closed | -$845K | – | 318 |
|
|
2025
Q1 | $845K | Buy |
+55,000
| New | +$845K | 0.22% | 85 |
|
|
2017
Q1 | – | Sell |
-13,000
| Closed | -$471K | – | 233 |
|
|
2016
Q4 | $471K | Buy |
+13,000
| New | +$471K | 0.05% | 130 |
|
|
2015
Q2 | – | Sell |
-51,650
| Closed | -$3.22M | – | 76 |
|
|
2015
Q1 | $3.22M | Buy |
+51,650
| New | +$3.22M | 0.94% | 22 |
|
|
2014
Q2 | – | Sell |
-21,000
| Closed | -$1.11M | – | 159 |
|
|
2014
Q1 | $1.11M | Buy |
+21,000
| New | +$1.11M | 0.08% | 107 |
|